Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-083422
Filing Date
2023-07-24
Accepted
2023-07-24 16:02:52
Documents
5
Effectiveness Date
2023-07-24

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2321841d1_s8.htm S-8 63141
2 EXHIBIT 5.1 tm2321841d1_ex5-1.htm EX-5.1 7827
3 EXHIBIT 23.2 tm2321841d1_ex23-2.htm EX-23.2 2183
4 EXHIBIT 107 tm2321841d1_ex-filingfees.htm EX-FILING FEES 10345
5 GRAPHIC tm2321841d1_ex51img001.jpg GRAPHIC 3015
  Complete submission text file 0001104659-23-083422.txt   88939
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273389 | Film No.: 231105048
SIC: 2834 Pharmaceutical Preparations